Please Wait.....
Report
Asia Pacific Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
Market Report I 2023-06-30 I 134 Pages I The Insight Partners
The Asia Pacific clinical trial imaging market is expected to grow from US$ 373.46 million in 2023 to US$ 553.11 million by 2028; it is estimated to register a CAGR of 8.2% from 2023 to 2028.
AI-Driven Clinical Trials to Fuel Asia Pacific Clinical Trial Imaging Market During Forecast Period
Artificial Intelligence (AI) aids in effective data collection and management and, thus, acts as a game changer for life science companies involved in the drug development process. The adoption of AI drives innovative ways of collecting clinical trial data and reducing dependency on manual operations. This can be well illustrated by the following used case: AstraZeneca has collected oncology data, including clinical and imaging data, of more than 100,000 consenting patients for different clinical studies. To transform the process of oncology data feed, the team adopts complex datasets for accessibility, interoperability, and reusability of data through "FAIR." Such integration allows the collected data from specific clinical trials and projects to be accessible across the company's drug development teams, in compliance with data protection laws. Further, AstraZeneca is working with external companies such as Tempus to leverage real-world data and represent patients across the region. Such strategic partnerships/inorganic strategies offer crucial evidence about patient outcomes in a healthcare system without revealing the identity of the clinical trial participants in the datasets. Thus, the increasing application of AI for processing clinical trial data is likely to catalyze the growth of the Asia Pacific clinical trial imaging market in the coming years.
Asia Pacific Clinical Trial Imaging Market Overview
The Asia Pacific clinical trial imaging market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share in the market in 2022, and it is expected to register the highest CAGR of 8.6% during the forecast period. The growth is due to the established pharmaceutical, a rise in R&D expenditure by the pharmaceutical and biopharmaceutical companies, a surge in clinical trials due to lower cost, well-established healthcare technologies, the launch of innovative products by key players, and favorable regulatory policies. China has the world's second-largest pharmaceutical market. The excessive population in China, coupled with the rise of various communicable and noncommunicable diseases, is majorly driving the growth of pharmaceutical companies in China.
Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Clinical Trial Imaging Market Segmentation
The Asia Pacific clinical trial imaging market is segmented on the basis of modality, offering, end user, and country.
Based on modality, the Asia Pacific clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. The tomography segment registered the largest market share in 2023.
Based on offering, the Asia Pacific clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The operational imaging services segment held the largest market share in 2023.
Based on end user, the Asia Pacific clinical trial imaging market is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. The contract research organizations (CROs) segment held the largest market share in 2023.
Based on country, the market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the market share in 2023.
Calyx Inc, eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, Radiant Sage LLC, VIDA Diagnostics Inc, and WCG Clinical Inc are the leading companies operating in the Asia Pacific clinical trial imaging market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Asia Pacific Market Segmentation
1.3.1 Asia Pacific Clinical Trial Imaging Market - by Modality
1.3.2 Asia Pacific Clinical Trial Imaging Market - by Offering
1.3.3 Asia Pacific Clinical Trial Imaging Market - by End User
1.3.4 Asia Pacific Clinical Trial Imaging Market - by Country
2. Asia Pacific Clinical Trial Imaging Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Clinical Trial Imaging Market - Market Landscape
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Clinical Trial Imaging Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
5.1.2 Spur in Number of CROs Offering Medical Imaging Services
5.2 Market Restraints
5.2.1 High Investment and Standardized Infrastructure Requirements
5.3 Market Opportunities
5.3.1 In-Silico Imaging Clinical Trials
5.4 Future Trends
5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis
6. Asia Pacific Clinical Trial Imaging Market
6.1 Asia Pacific Clinical Trial Imaging Market Revenue Forecast and Analysis
7. Asia Pacific Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality
7.1 Overview
7.2 Asia Pacific Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
7.3 Tomography
7.3.1 Overview
7.3.2 Tomography: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Ultrasound
7.4.1 Overview
7.4.2 Ultrasound: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Positron Emission Tomography
7.5.1 Overview
7.5.2 PET: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.6 X-Ray
7.6.1 Overview
7.6.2 X-Ray: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Echocardiography
7.7.1 Overview
7.7.2 Echocardiography: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Magnetic Resonance Imaging
7.8.1 Overview
7.8.2 Magnetic Resonance Imaging: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.9 Others
7.9.1 Overview
7.9.2 Others: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering
8.1 Overview
8.2 Asia Pacific Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
8.3 Trial Design Consulting Services
8.3.1 Overview
8.3.2 Trial Design Consulting Services: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Read Analysis Services
8.4.1 Overview
8.4.2 Read Analysis Services: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Operational Imaging Services
8.5.1 Overview
8.5.2 Operational Imaging Services: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Imaging Software
8.6.1 Overview
8.6.2 Imaging Software: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User
9.1 Overview
9.2 Pharmaceutical and Biopharmaceutical Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biopharmaceutical Companies: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.3 Contract Research Organizations
9.3.1 Overview
9.3.2 Contract Research Organizations: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Academic and Research Institutes
9.4.1 Overview
9.4.2 Academic and Research Institutes: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Country Analysis
10.1 Overview
10.1.1 Asia Pacific: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
10.1.1.1 China: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 China: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.2 China: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.1.3 China: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.1.4 China: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.1.2 Japan: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Japan: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.2 Japan: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.2.3 Japan: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.2.4 Japan: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.1.3 India: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 India: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.2 India: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.3.3 India: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.3.4 India: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.1.4 South Korea: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 South Korea: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.2 South Korea: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.4.3 South Korea: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.4.4 South Korea: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.1.5 Australia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Australia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.2 Australia: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.5.3 Australia: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.5.4 Australia: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Rest of Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.2 Rest of Asia Pacific: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
11. Asia Pacific Clinical Trial Imaging Market - Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 eResearch Technology Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Calyx Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 ICON PLC
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 VIDA Diagnostics Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 WCG Clinical Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medical Metrics Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Radiant Sage LLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 IXICO plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. China Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 3. China Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 4. China Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 8. India Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 9. India Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 10. India Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 11. South Korea Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 12. South Korea Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 15. Australia Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
Table 21. Recent Organic Growth Strategies in Clinical Trial Imaging Market
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Clinical Trial Imaging Market Segmentation
Figure 2. Asia Pacific Clinical Trial Imaging Market, by Country
Figure 3. Asia Pacific Clinical Trial Imaging Market Overview
Figure 4. Asia Pacific Clinical Trial Imaging Market, By Modality
Figure 5. Asia Pacific Clinical Trial Imaging Market, By Country
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Asia Pacific Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
Figure 9. Tomography: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 10. Ultrasound: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. PET: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. X-Ray: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Echocardiography: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Magnetic Resonance Imaging: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Asia Pacific Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
Figure 17. Trial Design Consulting Services: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Read Analysis Services: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Operational Imaging Services: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Imaging Software: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Asia Pacific Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
Figure 23. Pharmaceutical and Biopharmaceutical Companies: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Contract Research Organizations: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Academic and Research Institutes: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Asia Pacific Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Asia Pacific: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. China Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Japan Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. India Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. South Korea Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Australia Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security